Everest Medicines Acquires Hasten Biopharmaceuticals
Everest Medicines acquired Hasten Biopharmaceuticals for $150.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Everest Medicines
- Acquired Company
- Hasten Biopharmaceuticals
- Price
- $150.0M
- Acquisition Type
- Acquisition
- Announced
- March 18, 2026
Canonical: https://fsome.com/acquisitions/everest-medicines-acquires-hasten-biopharmaceuticals-17210969 · For the full deal terms, timeline, and press references, please enable JavaScript.